Pfizer news from FierceHealthcare
NewsSurprising facts about pharma's best paid pill-pushing docs
When doctors discuss what a medication can do, it confers a veneer of respectability on the drug company's marketing. But a ProPublica investigation uncovered that fewer than half of the best paid Read more...
Medical educators in Pennsylvania received at least $10 million from drug companies in 2009
Conflict-of-interest allegations aside, several Pittsburgh-area doctors and nurse educators are insisting that their work is not compromised despite data showing they were paid roughly $3.5 million Read more...
Lilly exec will explore links to industry at Harvard
An executive with Eli Lilly has accepted a job with Harvard Medical School that will entail studying the relationship between the school's researchers and the pharmaceutical industry. William Chin, Read more...
Stanford: Pfizer will fund our med school curriculum with 'no strings attached'
Is it possible for one of the world's largest and most influential drug companies to endorse a continuing education program for one of the most well-known universities in the U.S., with no strings Read more...
Trial data on Neurontin may have been manipulated
A new paper published in the New England Journal of Medicine has accused drugmaker Pfizer of manipulating clinical data on trials of anti-seizure drug Neurontin (gabapentin). The accusations stem Read more...
Pfizer pays $2.3B penalty for off-label drug marketing
Pfizer has agreed to pay a mammoth $3.2 billion penalty for marketing off-label uses of several of its drugs, a settlement which the U.S. Department of Justice has labeled the largest healthcare Read more...
Coming into the home stretch, pharma spends big on lobbying
With health reform set for one of the biggest remakes in U.S. history, it's little wonder that health players are spending big bucks on lobbying Capitol Hill. But of all the moneyed healthcare Read more...
Drugmaker rebates short-circuit impact of health plan co-pays
In theory, the co-pay system is supposed to encourage smart shopping without sacrificing patients' health. Patients pay higher portions of the bill--sometimes more than double--for pricier branded Read more...
Case study: Miami drug reps not registering as lobbyists
Right now, sentiment is high on Capitol Hill to expose the money flowing to doctors from pharmaceutical and medical device companies. A look at what's happening in some markets right now, however, Read more...
Baystate Medical subpeonaed for anesthesiologist's records
Federal investigators are now digging into the financial records of a Massachusetts anesthesiologist and former head of the acute pain unit at Baystate Medical Center in Springfield. Dr. Scott Reuben Read more...
| Press ReleasesPfizer And MIT Break Ground On New Research Units In Kendall Square10-year lease marks a strategic partnership between the academic research community and industry to boost innovation; building completion expected at end of 2013 NEW YORK and CAMBRIDGE, Mass.--( Read more >> Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With AnalystsNEW YORK--(BUSINESS WIRE)-- Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, August 2, Read more >> Unity Management Group, MCC Closes Deal with PfizerEAST HANOVER, N.J., June 13, 2011 /PRNewswire/ -- Unity Management Group, Inc. (OTC: UYMG) "UNITY" (or the "Company") (MCC) Metropolitan Computing Corporation is proud to announce it has received an Read more >> Pfizer Invites Public To Listen To Webcast Of April 28 Annual Meeting Of ShareholdersNEW YORK--(BUSINESS WIRE)-- Pfizer Inc. invites investors and the general public to listen to a Webcast of the Annual Meeting of Shareholders at 8:30 a.m. (Central Daylight Time) on Thursday, April Read more >> Inhibitex to Present at the ROTH 23rd Annual Growth Stock ConferenceATLANTA--(BUSINESS WIRE)-- Inhibitex, Inc. (Nasdaq: INHX), today announced that Russell Plumb, president and chief executive officer, will present an overview of the Company and an update of its Read more >> |
